Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : Nktr save search
Nektar Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-03 (Crawled : 00:00) - biospace.com/
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -0.84%
therapeutics financial results
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
Published: 2022-04-29 (Crawled : 12:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -3.61%
H: 3.02%
C: 2.02%
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 2.43%
H: 2.84%
C: -2.13%
Celsion Corporation Reports 2021 Financial Results and Provides Business Update
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 1.97%
H: 0.0%
C: -5.11%
corporation results
Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -1.1%
H: 4.15%
C: 3.75%
financial results therapeutics report results
Investors Go with Their Gut, Dropping $236M into Kallyope
Published: 2022-02-15 (Crawled : 16:00) - biospace.com/
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 1.57%
H: 2.63%
C: 1.36%
drop
Nektar Therapeutics Reports Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 22:00) - biospace.com/
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 4.52%
H: 0.0%
C: -6.41%
financial results results therapeutics
RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights
Published: 2021-08-26 (Crawled : 12:15) - biospace.com/
RDHL | $0.4301 11.57% 10.37% 660K
|
Health Technology
|
| O: 4.46%
H: 3.33%
C: -2.8%
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -0.62%
H: 1.67%
C: -0.7%
biopharma financial results results
Abingworth's $582 Million Co-Development Fund Will Propel Late-Stage Trials
Published: 2021-05-10 (Crawled : 14:00) - biospace.com/
NKTR | News | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: 0.35%
H: 0.4%
C: -2.18%
trial
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.